Do organic substances act as a degradable binding matrix in calcium oxalate kidney stones?
Chelating agents
Chemolysis
Enzymes
Organic compounds
Journal
BMC urology
ISSN: 1471-2490
Titre abrégé: BMC Urol
Pays: England
ID NLM: 100968571
Informations de publication
Date de publication:
26 Mar 2021
26 Mar 2021
Historique:
received:
10
02
2021
accepted:
18
03
2021
entrez:
26
3
2021
pubmed:
27
3
2021
medline:
27
8
2021
Statut:
epublish
Résumé
Calcium oxalate (CaOx) stones are considered to be highly resistant to chemolysis. While significant organic matter has been identified within these stones, which is presumed to bind (inorganic) CaOx particles and aggregates, most chemolysis efforts have focused on methods to attack the CaOx components of a stone. We examine the feasibility of inducing chemolysis of CaOx kidney stones, within hours, by specifically attacking the organic matrix present in these stones. In contrast to previous studies, we focused on the possible "brick and mortar" stone configuration. We systematically tested, via in vitro experiments, the ability of an extensive range of 26 potential chemolysis agents to induce relatively fast disintegration (and/or dissolution) of a large set of natural CaOx stone fragments, extracted during endourological procedures, without regard to immediate clinical application. Each stone fragment was monitored for reduction in weight and other changes over 72 h. We find that agents known to attack organic material have little, if any, effect on stone chemolysis. Similarly, protein and enzymatic agents, and oral additive medical treatments, have little immediate effect. These findings suggest that the organic and inorganic constituents present in CaOx stones are not structured as "brick and mortar" configurations in terms of inorganic and organic components.
Sections du résumé
BACKGROUND
BACKGROUND
Calcium oxalate (CaOx) stones are considered to be highly resistant to chemolysis. While significant organic matter has been identified within these stones, which is presumed to bind (inorganic) CaOx particles and aggregates, most chemolysis efforts have focused on methods to attack the CaOx components of a stone. We examine the feasibility of inducing chemolysis of CaOx kidney stones, within hours, by specifically attacking the organic matrix present in these stones.
METHODS
METHODS
In contrast to previous studies, we focused on the possible "brick and mortar" stone configuration. We systematically tested, via in vitro experiments, the ability of an extensive range of 26 potential chemolysis agents to induce relatively fast disintegration (and/or dissolution) of a large set of natural CaOx stone fragments, extracted during endourological procedures, without regard to immediate clinical application. Each stone fragment was monitored for reduction in weight and other changes over 72 h.
RESULTS
RESULTS
We find that agents known to attack organic material have little, if any, effect on stone chemolysis. Similarly, protein and enzymatic agents, and oral additive medical treatments, have little immediate effect.
CONCLUSIONS
CONCLUSIONS
These findings suggest that the organic and inorganic constituents present in CaOx stones are not structured as "brick and mortar" configurations in terms of inorganic and organic components.
Identifiants
pubmed: 33765979
doi: 10.1186/s12894-021-00818-3
pii: 10.1186/s12894-021-00818-3
pmc: PMC7995742
doi:
Substances chimiques
Calcium Oxalate
2612HC57YE
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
46Références
Urol Res. 2001 Apr;29(2):83-8
pubmed: 11396733
Clin Chim Acta. 2002 Aug;322(1-2):29-36
pubmed: 12104078
BMC Urol. 2005 May 22;5:9
pubmed: 15907215
Urolithiasis. 2013 Aug;41(4):323-6
pubmed: 23743991
Sci Rep. 2018 Sep 13;8(1):13731
pubmed: 30213974
Pediatr Nephrol. 2010 Jan;25(1):49-59
pubmed: 21476230
Free Radic Biol Med. 1993 Dec;15(6):645-51
pubmed: 8138191
Am J Physiol Renal Physiol. 2008 Feb;294(2):F355-61
pubmed: 18077596
Nat Rev Dis Primers. 2016 Feb 25;2:16008
pubmed: 27188687
Urolithiasis. 2017 Feb;45(1):11-18
pubmed: 27900406
Sci Rep. 2017 May 3;7(1):1415
pubmed: 28469190
Calcif Tissue Int. 1988 Nov;43(5):319-27
pubmed: 3145798
Rev Urol. 2009 Summer;11(3):134-44
pubmed: 19918339
Eur J Pharmacol. 2012 Aug 15;689(1-3):219-25
pubmed: 22713548
Proteome Sci. 2016 Feb 27;14:4
pubmed: 26924944
World J Urol. 2015 Feb;33(2):157-69
pubmed: 25465911
Urology. 2011 Sep;78(3):721.e13-721.e17
pubmed: 21741690
BMJ. 2016 Mar 14;352:i52
pubmed: 26977089
Am J Med. 1968 Nov;45(5):673-83
pubmed: 5687257
Urol Res. 2012 Jun;40(3):205-9
pubmed: 22089056
J Endourol. 2012 Feb;26(2):110-8
pubmed: 21999455
Kidney Int. 1996 Mar;49(3):880-8
pubmed: 8648933
Int Braz J Urol. 2013 Jan-Feb;39(1):103-7
pubmed: 23489502
Urol Int. 2014;92(3):349-55
pubmed: 24246673
Urolithiasis. 2019 Aug;47(4):311-320
pubmed: 30915494
J Urol. 1956 Sep;76(3):213-27
pubmed: 13368269